Vodafone shares near £1 as buyback filing hits and valuation debate sharpens

Vodafone shares near £1 as buyback filing hits and valuation debate sharpens

NEW YORK, December 31, 2025, 03:53 ET

  • Vodafone shares traded around 99 pence on Wednesday, hovering just below the £1 mark.
  • Vodafone said it repurchased 12.38 million shares in its latest tranche of an ongoing buyback programme.
  • A Simply Wall St analysis published last week put fair value below the recent close and showed most analyst price targets under £1.

Vodafone shares hovered just below the £1 level on Wednesday, trading at about 99.22 pence in London, as the telecoms group continued a steady run of share buybacks into year-end.

The move matters because the one-pound mark is a psychological threshold for retail and institutional investors in the U.K., where Vodafone is a heavyweight in the FTSE 100.

It also comes as trading volumes thin out around the holidays, making price levels and corporate buying programmes more visible in daily market moves.

In a regulatory filing on Tuesday, Vodafone said it repurchased 12,383,048 ordinary shares on Dec. 29 at prices between 96.60 pence and 98.02 pence, paying a volume-weighted average price of 97.62 pence. A buyback is when a company repurchases its own shares; treasury shares are typically not entitled to dividends and carry no voting rights.

Vodafone said it would hold the shares in treasury, taking its treasury holdings to 1,352,076,203 shares, with 23,525,884,554 shares in issue excluding treasury stock, the filing showed.

The stock ended Tuesday at 98.54 pence and remained about 10% below its 52-week high of £1.09 set on Dec. 19, MarketWatch data showed.

A Yahoo Finance UK column published this week said Vodafone was trading close to its 2025 highs and “might only be weeks” from reaching the £1 level. https://uk.finance.yahoo.com/news/forecast-vodafone-share-price-pass-070000000.html

Not everyone sees more upside at current levels. In an analysis published Dec. 22, Simply Wall St said its most-followed “narrative” put Vodafone’s fair value at about 90 pence, and cited a consensus analyst price target of £0.858, with estimates ranging from £0.60 to £1.36. https://simplywall.st/stocks/gb/telecom/lse-vod/vodafone-group-shares/news/assessing-vodafone-lsevods-valuation-following-its-recent-sh

The same analysis said Vodafone traded at about 0.7 times sales versus an “industry average” closer to 1.6 times, suggesting the market still prices in execution risk even after the recent rally.

Simply Wall St also pointed to weak execution in Germany and the complexity of large-scale restructuring as factors that could derail margin improvements assumed by more optimistic forecasts.

Vodafone competes with BT Group’s EE and Hutchison’s Three in the U.K. market, and faces European rivals including Orange and Telefónica across its footprint.

Shan Ahmed Khan

Shan Ahmed Khan is a senior markets reporter at TS2.tech. His coverage ranges from stocks and technology to economic developments across global markets. He worked in investment research and market analysis before becoming a financial journalist and is a graduate of the Lahore University of Management Sciences (LUMS).

US Stock Market Today Updates

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 Strong Buy

NVIDIA

94/100
#2 Strong Buy

Meta Platforms

89/100
#3 Buy

Alphabet

87/100
#4 Buy

Amazon

84/100
#5 Selective Buy

Microsoft

80/100
View full portfolio
Editorial model selection. Not personalised advice.
MARKET CALENDAR

Key Events Today

The catalysts most likely to move markets.

#1

Warsh at Jackson Hole

Policy tone can move rates, USD, equities, gold and crypto simultaneously.

#2

Michigan sentiment

A weak final reading or elevated inflation expectations could pressure risk assets.

#3

Chicago PMI

A surprise versus 58.0 may alter the near-term manufacturing-growth narrative.

View full calendar
Times and estimates may change. Verify before trading.
ADMA Biologics stock slides nearly 4% as biotech weakens in thin year-end trade
Previous Story

ADMA Biologics stock slides nearly 4% as biotech weakens in thin year-end trade

Meta stock slips after-hours as scam-ad scrutiny mounts, Manus AI deal draws focus
Next Story

Meta stock slips after-hours as scam-ad scrutiny mounts, Manus AI deal draws focus